Member Info for upomega

This may be of some comfort to investors.
I held BTG for a number of years. Woddford investments along with Invesco invested heavily a number of years ago. The company was taken over by Boston pharma six months ago. It is a pure cash offer which has yielded all long term holders with a substantial profit. Funds are due to be distributed this month . Which will Yield Woodford investments many millions. So in summary his fund should be bolstered considerably over the next few weeks. ONMHO so dyor

NewKotb

Thanks for the reply.. Very good analysis of current matters with regards to trading pattern and share price. It does look like you are going to be right on this. Hopefully the price will approach the £2.00 mark before anything transpires. I also hold omega diagnostics which i have mentioned before. What is interesting is that the reverse has been happening with the share price.

newKOTB
I,m not sure if the end game is approaching if you are referring to some kind of offer. As of today no new investor has gone over three per cent. . So inmo I can not see any offer suddenly appearing. Its probably just down to new p,i investors coming on board with existing ones unloading in small amounts.

Unfortunately the spiv brigade thinks overwise

The trade of one share could simply be the rounding up or down on tolerance after an order on sets has gone through.. This type of thing used to happen through Euroclear to settle a block trade . Either stock or cash would be sold/purchased to flatten a position. Crest is now part of Euroclear so I would imagine the mechanics are similar.

Below is my post on ADVFN, but it doesn't show for some reason ?
Re posted as my orginal was posted from a phone

Agree food intolerance is currently the only segment worth anything. Maybe someone could answer the question as to why this segment isn,t being pushed more. For example more strategic partnerships sought.

If they are serious about shareholder value they should push for a sale of the other two divisions. Maybe an aid agency would be interested in taking on Visetect. I am now more concerned that they will not be able to sell the product effectively without some kind of partnership as they do not seem to have an effective sales force in place. The share price is a joke . Closed period or not someone needs to address this.I.E the house broker.
Also it may even add shareholder if they gave it away. At least the company would be profitable with future growth hopefully coming from China

One thought. If the company in the short term is not going to purchase an asset .Maybe a share buyback would be prudent. Inmo the longer the price remains at these levels a takeover will become innevatable. At least if they bought back some shares it would give them some protection

Hi newKOTB

I hold these together with omega. In my view the same thing is happening to them,but on a worse scale as each movement on orchestrated trades effects the price by five percent

Hi
the only reason I can think of is the lack of pi investors. So any sale of the shares will have a distorted effect on the share price. I have posted on advfn in the past under the same username. So you can view my postings on there. A couple of posters on there have raised a valid point inmo in that the current bod of directors have invested hardly anything in terms of shares. My view was that it could be down to a closed period or lack of funds, but I do feel that a token investment should be made at some point as this would at least send some kind of message out to current shareholders